TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-2,415 Cr | ₹-197 Cr | ₹-449 Cr | ₹199 Cr | ₹-241 Cr |
What is the latest Cash Flow from Investing Activities ratio of TORRENT PHARMACEUTICALS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2023 | ₹-2,415 Cr |
Mar2022 | ₹-197 Cr |
Mar2021 | ₹-449 Cr |
Mar2020 | ₹199 Cr |
Mar2019 | ₹-241 Cr |
How is Cash Flow from Investing Activities of TORRENT PHARMACEUTICALS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-2,415 Cr | Negative | |
Mar2022 | ₹-197 Cr | Negative | |
Mar2021 | ₹-449 Cr | Negative | |
Mar2020 | ₹199 Cr | Positive | |
Mar2019 | ₹-241 Cr | - |
Compare Cash Flow from Investing Activities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹89,351.1 Cr | -1.7% | 3% | 65.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -1.7% |
3% |
65.8% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses